Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H12N2OS |
| Molecular Weight | 268.334 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1NC(=S)NC1(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=AMDPNECWKZZEBQ-UHFFFAOYSA-N
InChI=1S/C15H12N2OS/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)
| Molecular Formula | C15H12N2OS |
| Molecular Weight | 268.334 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer. | 2010-12-01 |
|
| Anti-angiogenic action of 5,5-diphenyl-2-thiohydantoin-N10 (DPTH-N10). | 2008-11-28 |
|
| Three modified activated carbons by different ligands for the solid phase extraction of copper and lead. | 2008-04-15 |
|
| Structure and anti-proliferation function of 5,5-diphenyl-2-thiohydantoin (DPTH) derivatives in vascular endothelial cells. | 2007-08-17 |
|
| Anti-proliferation effect of 5,5-diphenyl-2-thiohydantoin (DPTH) in human vascular endothelial cells. | 2004-01-01 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:31:47 GMT 2025
by
admin
on
Mon Mar 31 19:31:47 GMT 2025
|
| Record UNII |
13Y6ZC0YR8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000127546
Created by
admin on Mon Mar 31 19:31:47 GMT 2025 , Edited by admin on Mon Mar 31 19:31:47 GMT 2025
|
PRIMARY | |||
|
13Y6ZC0YR8
Created by
admin on Mon Mar 31 19:31:47 GMT 2025 , Edited by admin on Mon Mar 31 19:31:47 GMT 2025
|
PRIMARY | |||
|
SUB33631
Created by
admin on Mon Mar 31 19:31:47 GMT 2025 , Edited by admin on Mon Mar 31 19:31:47 GMT 2025
|
PRIMARY | |||
|
854150
Created by
admin on Mon Mar 31 19:31:47 GMT 2025 , Edited by admin on Mon Mar 31 19:31:47 GMT 2025
|
PRIMARY | |||
|
82311
Created by
admin on Mon Mar 31 19:31:47 GMT 2025 , Edited by admin on Mon Mar 31 19:31:47 GMT 2025
|
PRIMARY | |||
|
21083-47-6
Created by
admin on Mon Mar 31 19:31:47 GMT 2025 , Edited by admin on Mon Mar 31 19:31:47 GMT 2025
|
PRIMARY | |||
|
244-201-3
Created by
admin on Mon Mar 31 19:31:47 GMT 2025 , Edited by admin on Mon Mar 31 19:31:47 GMT 2025
|
PRIMARY | |||
|
DTXSID9066677
Created by
admin on Mon Mar 31 19:31:47 GMT 2025 , Edited by admin on Mon Mar 31 19:31:47 GMT 2025
|
PRIMARY |